-
2022-502518-98-00
5
2024-04-26
nonsegmental vitiligo
-
2023-506917-23-00
4
2024-04-19
patients with mild to moderate left-sided ulcerative colitis
-
2022-501172-25-00
5
2024-01-17
Chronic and Episodic Migraine
-
2022-502442-27-00
5
2024-01-08
Obesity
-
2023-505120-59-00
5
2023-12-19
Moderate to Severe Plaque Psoriasis
-
2023-505122-34-00
5
2023-12-05
Plaque Psoriasis
-
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2022-501419-15-00
5
2023-08-23
Atrial Fibrillation
-
2022-501999-26-00
5
2023-07-12
Severe Hypertriglyceridemia (SHTG)
-
2024-515027-11-00
4
2023-06-29
Crohn’s disease
-
2022-500290-14-01
4
2023-05-11
Colitis ulcerative
-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2024-513460-26-00
5
2023-03-29
Refractory Chronic Cough, Including Unexplained Chronic Cough
-
2022-501744-15-00
5
2023-01-23
Obesity, Overweight
-
2023-508559-37-00
5
2022-07-14
Lupus nephritis
-
2023-504737-41-00
5
2022-06-10
Moderately to Severely Active Crohn's Disease
-
2023-507795-51-00
5
2022-05-17
atherosclerotic heart and blood vessel disease (the narrowing of arter
-
2023-506256-25-00
5
2021-10-20
Active Psoriatic Arthritis
-
2023-504734-21-00
5
2021-08-30
Psoriatic arthritis (PsA)
-
2023-504716-15-00
6
2021-08-06
Psoriatic Arthritis
-
2023-504447-14-00
10
2021-07-29
Treatment of pediatric subjects with moderate to severe chronic plaque
-
2023-509066-38-00
4
2021-04-16
Atrial Fibrillation
-
2023-503568-18-00
5
2021-04-13
Early human epidermal growth factor receptor 2 (HER2) positive breast
-
2022-501645-70-00
5
2020-11-25
Crohns Disease